Microbot Medical (MBOT) announced the appointment of Michal Ahuvia, to the newly created role of Director of Operations. In this role, Ahuvia will assume responsibility to ramp-up production and improve production efficiencies as the Company prepares for the planned commercial launch of LIBERTY, which is anticipated in the second quarter of 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBOT:
- Microbot Medical appoints David Wilson to board of directors
- Microbot Medical closes $8.6M registered direct offering
- Largest borrow rate increases among liquid names
- Microbot Medical prices 3.79M shares at $2.27 in registered direct offering
- Microbot Medical to sell 4M shares at $1.75 in registered direct offering